中文摘要 前胡屬台灣特有種台灣前胡 (繖形科) 是多年生草本植物,主要分佈於本島中高海拔山區,因為與中藥前胡同屬,其根部為傳統民間用藥,具有解熱、鎮咳、鎮痛、袪痰等作用。由於篩選其根部甲醇萃出物發現具有抗血小板凝集活性,故這次研究是採集台灣前胡之根部,進行成分分離,且研究分離化合物之抗血小板凝集活性。 從台灣前胡甲醇萃取液之不可溶部分,獲得到大量D-mannitol (1),而氯仿可溶部分,則分離得到31個巳知化合物。包括25個coumarin類: bergapten (2),isoimperatorin (3),(–)-deltoin (4),xanthotoxin (5), praeruptorin E (8),hyuganin A (9),(–)-peujaponisin (10),(–)-isosamidin (11),(+)-peuformosin (12),(+)-anomalin (13),(+)-cis-3’-acetoxy-4-(2-methylbutyroyloxy)-3’,4’-dihydroseselin (14), cis-3’-hydroxy-4’-isovaleryloxy-3’,4’-dihydroseselin (15),laserpitin (16),(–)-cis-3’-hydroxy-4’-(2-methylbutyroyloxy)-3’,4’-dihydroseselin (17),(+)-marmesin (18),isoscopoletin (19),umbelliferone (20), psoralen (24), (+)-lomatin (25),isofraxidin (26),(–)-cis-khellactone (27), (+)-3’-hydroxymarmesin (28),(+)-rutaretin (29),(+)-oxypeucedanin hydrate (30),(+)-dorsteniol (31);1 個monoglyceride 之1-O-hexadecanoyl glycerol (32),固醇類β-sitosterol (6) 和stigamasterol (7) 之混何物;2個polyacetylene類之 falcarindiol (22),panaxynol (23) ;1個酚類 p-hydroxyphenethyl ferulate (21)。其結構依光譜數據而決定。 化合物 (2)、(3)、(4)、(5)、(18)、(20)、(24)、(26) 及 (30) 為本科室自其他植物分離到具有抗血小板凝集活性,而 (7)、(22)、(23) 及 (27) 由文獻亦巳知具有此活性。(11)、(12)則對collagen 誘導之抗血小板凝集顯現活性。
Abstract Peucedanum formosanum Hay. (Umbelliferae) is an endemic perennial herb in Taiwan, distributes at medium to high altitudes through the Island. Its root was used as folk medicine to treat cough, fever, headache and sputum caused by colds like the traditional Chinese medicine, Qain Hu. The methanolic extract of the root showed anti-platelet aggregation activity in preliminary screening. Investigation on the MeOH extract of the root led to the isolation of one saccharide, D-mannitol (1) from theparcipitate portion, thirty-one known compounds including coumarins bergapten (2), isoimperatorin (3), (–)-deltoin (4), xanthotoxin (5), praeruptorin E (8), hyuganin A (9), (–)-peujaponisin (10), (–)-isosamidin (11), (+)-peuformosin (12), (+)-anomalin (13), (+)-cis-3’-acetoxy-4-(2-methylbutyroyloxy)-3’,4’-dihydroseselin (14), cis-3’-hydroxy-4’-isovaleryloxy-3’,4’-dihydroseselin (15), laserpitin (16), (–)-cis-3’-hydroxy-4’-(2-methyl-butyroyloxy)-3’,4’-dihydroseselin (17), (+)-marmesin (18), isoscopoletin (19), umbelliferone (20), psoralen (24), (+)-lomatin (25), isofraxidin (26), (–)-cis-khellactone (27), (+)-3’-hydroxymarmesin (28), (+)-rutaretin (29), (+)-oxypeucedanin hydrate (30), and (+)-dorsteniol (31); one monoglyceride, 1-O-hexadecanoyl glycerol (32); mixture of β-sitosterol (6) and stigamasterol (7); two polyacetylenes falcaridiol (22), and panaxynol (23); one benzenoid, p-hydroxyphenethyl ferulate (21). The structures of isolates were elucidated by spectroscopic analysis. Among the isolates, compounds (2), (3), (4), (5), (18), (20), (24), (26) and (30) with anti-platelet aggregation activity were previously reported by our lab. The anti-platelet aggregation activity of (13), (22), (23) and (27) were also reported by other groups. Compouds (11) and (12) showed anti-platelet aggregation activity induced by collagen.